Ramiro
Jover Atienza
Ramiro Jover Atienza-rekin lankidetzan egindako argitalpenak (9)
2024
-
Idiosyncratic Drug-Induced Liver Injury and Amoxicillin–Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 13
2021
2019
-
A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease
Molecular Nutrition and Food Research, Vol. 63, Núm. 20
-
Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice
Molecular Nutrition and Food Research, Vol. 63, Núm. 8
2017
-
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
Free Radical Biology and Medicine, Vol. 102, pp. 188-202
2015
-
Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease
Molecular Nutrition and Food Research, Vol. 59, Núm. 5, pp. 879-893
-
Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease
Molecular Pharmacology, Vol. 87, Núm. 4, pp. 582-594
2014
-
Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin
Laboratory Investigation, Vol. 94, Núm. 3, pp. 262-274
2013
-
The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; And repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1831, Núm. 4, pp. 803-818